ReviewFrontiers in oncology2021

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor.

Nicola Sgherza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.